03:51 AM EST, 11/15/2024 (MT Newswires) -- Michael Halstead, President, on November 12, 2024, sold 41,583 shares in Intra-Cellular Therapies ( ITCI ) for $3,692,100.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1567514/000095017024127275/xslF345X05/ownership.xml
Price: 87.33, Change: -0.30, Percent Change: -0.34